Boothbay Fund Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.27M | Sell |
|
|||||
|
2025
Q2 | $3.13M | Sell |
|
|||||
|
2025
Q1 | $4.69M | Buy |
|
|||||
|
2024
Q4 | $7.04M | Buy |
|
|||||
|
2024
Q3 | $5.59M | Sell |
|
|||||
|
2024
Q2 | $6.76M | Sell |
|
|||||
|
2024
Q1 | $7.61M | Buy |
|
|||||
|
2023
Q4 | $5.16M | Sell |
|
|||||
|
2023
Q3 | $4.97M | Buy |
|
|||||
|
2023
Q2 | $1.74M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $208K | Buy |
|